Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient

Author： Baumgartner Iris  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.13, 2005-10, pp. : 2181-2192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candesartan Treatment for Peripheral Occlusive Arterial Disease after Stent Angioplasty: A Randomised, Placebo-Controlled Trial

By C. Schindler  

Clinical Drug Investigation, Vol. 25, Iss. 2, 2005-01 ,pp. : 89-97

Adis International

Access to resources Recommend Favorite

Peripheral Arterial Occlusive Disease as a Predictor of the Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease with and without Diabetes Mellitus

By Papanas N   Tziakas D   Maltezos E   Kekes A   Hatzinikolaou E   Parcharidis G   Louridas G   Hatseras D  

The Journal of International Medical Research, Vol. 32, Iss. 4, 2004-07 ,pp. : 422-428

Field House Publishing

Access to resources Recommend Favorite

Pharmacological Treatment of Patients with Peripheral Arterial Disease

By Kim C.K.   Schmalfuss C.M.   Schofield R.S.   Sheps D.S.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Drug Treatment of Peripheral Arterial Disease in the Elderly

By Aronow Wilbert S.  

Drugs & Aging, Vol. 23, Iss. 1, 2006-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Treatment strategies for peripheral arterial disease and claudication

By  

Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite